Skip to main content

Circulating Tumor Cell Technology Outlook (Revenue, USD Million, 2012 - 2022).

The growth of the circulating tumor cells (CTC) market is influenced by the increasing mortality rate due to cancer, several types of genetic disorders, drastic changes in lifestyle, an increase in smoking-causing disorders, and a rise in consumption of alcohol. Moreover, developments in bioengineering technologies, biomedical imaging, and the rise in demand for preventive medications for different types of cancers are also stimulating the market growth of circulating tumor cells. However, the factors restraining the market growth comprise the significant cost of detection techniques, scarcity of specific biomarkers for the detection of CTCs, reluctance in the adoption of new technologies, and other technical limits.

Download Free Sample  - https://www.millioninsights.com/industry-reports/circulating-tumor-cells-ctc-market/request-sample

The increasing focus of the market players for the introduction of companion diagnostics for cancer and other disorders and the increase in demand for research projects on cancer are a few trends in the circulating tumor cells industry. The circulating tumor cells market is categorized based on technology, application, and geography. Based on technology, the market is divided into CTC Detection, CTC Enrichment, and CTC Analysis. CTC enrichment segment is expected to lead the market owing to high efficiency due to increased functionalities.

Based on application, the circulating tumor cells (CTC) industry is divided into tumorigenesis research, cancer stem cell research, EMT biomarkers development, and others.EMT biomarkers development segment is predicted to hold the maximum share of the market due to advancements in technology. In terms of end-user, the circulating tumor cells (CTC) market is bifurcated into research & academic institutes, hospitals & clinics, and diagnostic centers. The hospitals and clinics segment is expected to hold a larger share of the market due to the increasing preference for efficient treatment offered at hospitals.

Geographically, the CTC industry is segmented as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America, followed by Europe accounted for the larger share of the market due to a large number of market players and mature healthcare infrastructure. Asia-Pacific is also expected to grow considerably in the coming years due to increasing investment and growing technological advancements in the domain.

The prominent players in the circulating tumor cells industry include ApoCell, Advanced Cell Diagnostics, Inc, ClearbridgeBiomedicsPte Ltd, Aviva Biosciences, CynvenioBiosystems, Inc, BioceptInc, MiltenyiBiotec, Menarini Silicon Biosystems, Qiagen, and CreatvMicrotech Inc.

Comments

Popular posts from this blog

Functional Tea Market is expected to boost the growth of the market over the forecast period.

Functional Tea refers to a series of teas that can contribute to bodily functions. In 2019, the market size of Functional Tea is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. Download Request sample copy -  https://www.innovationmarketresearch.com/market-reports/functional-tea-market/request-sample In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Functional Tea. This report studies the global market size of Functional Tea, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Functional Tea sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sal...

Which are the biggest markets (regions) for Insulin Pen?

    The global Insulin Pen market was valued at $XX million in 2018, and Radiant Insights analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Insulin Pen from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Insulin Pen market. Download Free Sample  -  https://www.radiantinsights.com/research/2013-2028-report-on-global-insulin-pen-market/request-sample Leading players of Insulin Pen including: Novo Nordisk Sanofi-Aventis Eli Lilly OWEN Mumford WOCKHARDT Dongbao(YPSOMED) Gan & Lee Market split by Type, can be divided into: Reusable Insulin Pen Disposable Insulin Pen Market split by Application, can be divided into: Hospitals Clinics The Chemist's Shops Market sp...

Mobile Marketing Market Trends & Scope, Product Estimates & Strategy Framework To 2014 - 2025

The global mobile marketing industry is expected to be directed by the Asia Pacific for the duration of the forecast. The development within the state can be credited to the growing purchasing power of the residents, increasing acceptance of smartphones, increasing accessibility to the networks of 3G & 4G along with the Internet, and the increasing alertness between business enterprises regarding the paybacks of the market for mobile marketing. Due to the huge number of service suppliers for mobile marketing together with the maximum infiltration percentage of smartphones, which is almost 77.0% of the entire populace in the U.S.A. North America detained nearby 41.0% share of revenue of the global market for mobile marketing in 2018. Additionally, improvement in the usage of OTT content is likely to bring about a substantial development of the regional market during the period of the forecast. Broadening the base of smartphone consumers, greater investment in the development of the ...